Audax Group announced it has completed an investment in Laborie Medical Technologies, Inc. (“Laborie”). Headquartered in Toronto, Ontario, Laborie is a leading global provider of urodynamic testing equipment and consumables for urinary incontinence. Laborie supplies physician offices, hospitals, and mobile providers on six continents. With Audax’ investment, Laborie intends to pursue organic growth opportunities and acquisitions to further its position as a leader in global pelvic health.
Geoffrey S. Rehnert,** Co-Chief Executive Officer, Audax Group, said “Laborie is a leading medical diagnostics and consumables business with exceptional brand recognition. We look forward to working with Rob Laborie and his management team to build the company through acquisitions and product line expansion.”
Rob Laborie, **CEO of Laborie, said “Audax Group is an ideal partner as we embark on our next stage of growth. Their operational expertise and successful track record working with medical device companies will be key resources for us as we continue to build our business.”
Oliver, Lipman & Associates advised Laborie. Kirkland & Ellis LLP and Stikeman Elliott LLP served as counsel to Audax Group. Bank of Montreal provided financing to support the investment.